Ovarian Cancer Clinical Trials in Houston

Showing 201-202 of 202 trials

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

NCT00190697

Patients who were previously enrolled on the LY353381 arm of any LY353381 oncology trial could enroll in this "roll-over" study if they had exhibited clinical benefit from treatment and wished to continue on treatment. Patients were monitored for safety.

Breast CancerEndometrial CancerOvarian Cancer

Eli Lilly and Company70 participantsStarted Jan 2001

Houston, Texas, United States

TERMINATEDPhase 3133 miles

Clinical Trial for Ovarian Cancer (OvaRex®)

NCT00050375

This study will compare the time to disease relapse between OvaRex® MAb-B43.13-treated patients and placebo-treated patients. This study will also compare assessments of survival, quality of life, immune response and safety between active and placebo groups.

Ovarian Cancer

Unither Pharmaceuticals354 participantsStarted Dec 2002

Huntsville, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +59 more locations

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer Trials in Other Cities

Other Conditions in Houston